Lifecore Biomedical Target Price

The latest target price for LFCR is $6.3. Investors often review this figure alongside Lifecore Biomedical's historical trend and sector peers before judging valuation or financial health.

Lifecore Biomedical trades near $6.42 while the consensus target sits at $6.3 (2.2% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting LFCR's target price ($6.3), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lifecore Biomedical's target price against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.